Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Current Provider-Administered Oncology Drug Policies .

Abraxane, Paclitaxel Albumin-Bound

Adcetris

Alimta, Pemfexy, Pemetrexed

Avastin, Mvasi, Zirabev, Alymsys, Vegzelma

Fosaprepitant: Emend®; Fosaprepitant Ψ; Focinvez Ψ

Erbitux

Faslodex, Fulvestrant

Halaven

Herceptin, Ogivri, Kanjinti, Trazimera, Herzuma, Ontruzant

print Print Back Back Immune Globulins (immunoglobulin) (Intravenous) Policy Number: VP-0071 Last Review Date:...

print Print Back Back Ixempra® (ixabepilone) (Intravenous) Policy Number: VP-0072 Last Review Date:...

Jevtana, Cabazitaxel

print Print Back Back Aloxi® (palonosetron) (Intravenous) Policy Number: VP-008  Last Review Date:...

print Print Back Back Nplate™ (romiplostim) (Subcutaneous) Policy Number: VP-0089 Last Review Date:...

print Print Back Back Kadcyla® (ado-trastuzumab emtansine) (Intravenous) Policy Number: VP-0092 ​ ...

Perjeta® (pertuzumab)

print Print Back Back Provenge® (sipuleucel-T) (Intravenous) Policy Number: VP-0100 Last Review Date:...

print Print Back Back Rituximab: Rituxan®, Truxima®, Ruxience®, Riabni™ (Intravenous) Policy Number: VP-0109...

print Print Back Back Bendamustine: Treanda®; Bendeka®; Belrapzo®; Vivimusta™; Bendamustine Ψ (Intravenous)...

Vectibix